28
Views
0
CrossRef citations to date
0
Altmetric
Methods In Addiction Research

Pilot investigation of an electronic pillbox at a community opioid treatment program

, &
Received 28 Aug 2023, Accepted 05 Feb 2024, Published online: 01 Apr 2024

References

  • Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;8:CD004145. doi:10.1002/14651858.CD004145.pub4.
  • Title 42, Part 8. Medication assisted treatment for opioid use disorder. Code of Federal Regulations; 2024.
  • Joudrey PJ, Edelman EJ, Wang EA. Drive times to opioid treatment programs in urban and rural counties in 5 U.S. states. JAMA. 2019;322:1310–12. doi:10.1001/jama.2019.12562.
  • Smith LR, Mittal ML, Wagner K, Copenhaver MM, Cunningham CO, Earnshaw VA. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS). Addiction. 2020;115:354–67. doi:10.1111/add.14799.
  • Bohnert AS, Bradshaw CP, Latkin CA. A social network perspective on heroin and cocaine use among adults: evidence of bidirectional influences. Addiction. 2009;104:1210–1210. doi:10.1111/j.1360-0443.2009.02615.x.
  • Substance Abuse and Mental Health Services Administration. Opioid treatment program guidance. 2020. https://www.samhsa.gov/coronavirus.
  • Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drug most frequently involved in drug overdose deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018 Dec;67:1–14. PMID:30707673.
  • Jones CM, Baldwin GT, Manocchio T, White JO, Mack KA. Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths — United States, 2002–2014. MMWR Morb Mortal Wkly Rep. 2016;65:667–71. doi:10.15585/mmwr.mm6526a2.
  • Centers for Disease Control and Prevention. Social distancing. 2020.
  • Substance Abuse and Mental Health Services Administration. Methadone take home flexibilities extension guidance. 2023. http://www.samhsa.gov/coronavirus.
  • Shahani A, Hieva HR, Czado K, Shannon E, Gaetani R, Gresham M, Garcia JC, Ganesan H, Cerciello E, Dave J, Jain R. An electronic pillbox intervention designed to improve medication safety during care transitions: challenges and lessons learned regarding implementation and evaluation. BMC Health Serv Res. 2022;22:1304.
  • Choi EP. A pilot study to evaluate the acceptability of using a smart pillbox to enhance medication adherence among primary care patients. Int J Environ Res Public Health. 2019;16:3964. doi:10.3390/ijerph16203964.
  • Dunn KE, Brooner RK, Stoller KB. Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic. J Subst Abuse Treat. 2021 Feb;121:108197. doi:10.1016/j.jsat.2020.108197.
  • Kidorf M, Brooner RK, Dunn KE, Peirce JM. Use of an electronic pillbox to increase the number of methadone take-home doses during the COVID-19 pandemic. J Subst Abuse Treat. 2021 Jul;126:108328. doi:10.1016/j.jsat.2021.108328.
  • McCarty D, Bougatsos C, Chan B, Hoffman KA, Priest KC, Grusing S, Chou R. Office-based methadone treatment for OUR and pharmacy dispensing: a scoping review. Am J Psychiatry. 2021 Sep;178:804–17. doi:10.1176/appi.ajp.2021.20101548.
  • Brooner RK, Stoller KB, Patel P, Wu L, Yan H, Kidorf M. Opioid treatment program prescribing of methadone with community pharmacy dispensing: pilot study of feasibility and acceptability. Drug Alcohol Depend Rep. 2022 Jun;3:100067. doi:10.1016/j.dadr.2022.100067.
  • Hallgren KA, Darnton J, Soth S, Blalock KL, Michaels A, Grekin P, Saxon AJ, Woolworth S, Tsui JI. Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take home dosing during the COVID-19 pandemic. J Subst Abuse Treat. 2022 Dec;143:108896. doi:10.1016/j.jsat.2022.108896.
  • Chai PR, Mohamed Y, Bustamante MJ, Goodman GR, Najarro J, Castillo-Mancilla J, Baez A, Bronzi O, Sullivan MC, Pereira LM, et al. DigiPrEP: a pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances. J Acquir Immune Defic Syndr. 2022;89:e5–15. doi:10.1097/QAI.0000000000002854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.